Home /
Insights /
Will Life Sciences Companies Face More Scrutiny in 2018?

Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

April 11 US Imposes New Russia Sanctions Targeting Oligarchs, Senior Government Officials and Entities skadden.com/insights/publi…
April 9 New York State Responds to Federal Tax Reform skadden.com/insights/publi…
April 9 New Legislation Will Benefit Business Development Companies While Closed-End Funds Remain in Limbo skadden.com/insights/publi…